2014年的乙型肝炎：乙肝病毒研究取得进展——受体与再激活 - Suppr | 超能文献

相似文献

1

Hepatitis B in 2014: HBV research moves forward--receptors and reactivation.2014年的乙型肝炎：乙肝病毒研究取得进展——受体与再激活

Nat Rev Gastroenterol Hepatol. 2015 Feb;12(2):70-2. doi: 10.1038/nrgastro.2014.226. Epub 2014 Dec 16.

2

Antiviral prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection.化疗引起慢性乙型肝炎病毒感染再激活的抗病毒预防

Clin Liver Dis. 2007 Nov;11(4):965-91, x. doi: 10.1016/j.cld.2007.08.006.

3

Hepatitis B virus receptors and molecular drug targets.乙型肝炎病毒受体与分子药物靶点。

Hepatol Int. 2016 Jul;10(4):567-73. doi: 10.1007/s12072-016-9718-5. Epub 2016 Mar 15.

4

[Treatment hepatitis B reactivation in the transplant].[移植中乙肝再激活的治疗]

Gastroenterol Hepatol. 2014 Jul;37 Suppl 2:55-61. doi: 10.1016/S0210-5705(14)70070-6.

5

Evaluating Hepatitis B Virus Reactivation During Solid Tumor Chemotherapy: Evidence to Guide Pretreatment Hepatitis B Screening and Prophylaxis.实体瘤化疗期间乙肝病毒再激活的评估：指导乙肝病毒感染筛查和预防的证据

Ann Intern Med. 2016 Jan 5;164(1):64-5. doi: 10.7326/M15-2722. Epub 2015 Nov 24.

6

Hepatitis B virus and hepatitis C virus treatment and management in patients receiving immune-modifying agents.接受免疫调节剂治疗的患者的乙型肝炎病毒和丙型肝炎病毒治疗与管理

Curr Opin Rheumatol. 2014 Jul;26(4):395-403. doi: 10.1097/BOR.0000000000000067.

7

Oncologists and hepatitis B: a survey to determine current level of awareness and practice of antiviral prophylaxis to prevent reactivation.肿瘤学家与乙型肝炎：一项旨在确定预防再激活的抗病毒预防当前认知水平和实践情况的调查。

Chemotherapy. 2009;55(2):69-75. doi: 10.1159/000183731. Epub 2008 Dec 12.

8

Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.HBV 核心抗体阳性的类风湿关节炎患者接受抗 TNF-α 治疗时病毒载量的动力学变化及乙型肝炎病毒再激活的风险。

Ann Rheum Dis. 2011 Oct;70(10):1719-25. doi: 10.1136/ard.2010.148783. Epub 2011 Jun 29.

9

Entecavir as a first-line treatment for hepatitis B virus reactivation following polychemotherapy for chronic lymphocytic leukemia and invasive ductal carcinoma: a report of two cases and review of the literature.

Eur J Gastroenterol Hepatol. 2015 Jan;27(1):39-45. doi: 10.1097/MEG.0000000000000115.

10

Direct-acting antiviral treatment in adults infected with hepatitis C virus: Reactivation of hepatitis B virus coinfection as a further challenge.直接作用抗病毒治疗成人丙型肝炎病毒感染：乙型肝炎病毒合并感染的再激活是一个进一步的挑战。

J Clin Virol. 2016 May;78:27-30. doi: 10.1016/j.jcv.2016.02.026. Epub 2016 Mar 3.

引用本文的文献

1

Emerging therapies for HBsAg seroclearance: spotlight on novel combination strategies.实现乙肝表面抗原血清学清除的新兴疗法：聚焦新型联合策略。

Hepatol Int. 2025 Jun 11. doi: 10.1007/s12072-025-10828-0.

2

Drug development for chronic hepatitis B functional cure: Recent progress.慢性乙型肝炎功能性治愈的药物研发：近期进展

World J Hepatol. 2025 Apr 27;17(4):105797. doi: 10.4254/wjh.v17.i4.105797.

3

Prospect of emerging treatments for hepatitis B virus functional cure.乙型肝炎病毒功能性治愈的新兴治疗前景。

本文引用的文献

1

Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: a prospective study.曾感染乙型肝炎病毒的淋巴瘤患者接受含利妥昔单抗化疗后乙型肝炎病毒再激活：一项前瞻性研究。

J Clin Oncol. 2014 Nov 20;32(33):3736-43. doi: 10.1200/JCO.2014.56.7081. Epub 2014 Oct 6.

2

Strategies to inhibit entry of HBV and HDV into hepatocytes.抑制 HBV 和 HDV 进入肝细胞的策略。

Gastroenterology. 2014 Jul;147(1):48-64. doi: 10.1053/j.gastro.2014.04.030. Epub 2014 Apr 25.

3

Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide.